Sfoglia per AUTORE
PARIS L
Collezione AOU Novara

  

Items : 2

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial. in Blood cancer journal / Blood Cancer J. 2021 Dec 7;11(12):197. doi: 10.1038/s41408-021-00590-5.

2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Cea M; Offidani M; Boccadoro M; Larocca A; Monaco F; Corradini P; Belotti A; Paris L; Grasso M; Aquino S; De Paoli L; Rota-Scalabrini D; Bonello F; Ballanti S; De Sabbata G; Zambello R; Tacchetti P; Cellini C; Patriarca F; Musolino C; Ciccone G; Capra A; Pescosta N; Petrucci MT; Bringhen S; Liberati AM; Mina R; Falcone AP;

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials. in Haematologica / Haematologica. 2020 Apr;105(4):1074-1080. doi: 10.3324/haematol.2019.220657. Epub 2019 Jun 27.

2020
AOU Città della Salute di Torino
AOU Novara

Montefusco V; Hájek R; Boccadoro M; Bringhen S; Palumbo A; De Paoli L; Romano A; Falcone AP; Zambello R; Giuliani N; Fraticelli V; Paris L; Amico V; Musto P; Innao V; Cangiolosi C; Bernardini A; Oddolo D; Benevolo G; Spada S; Patriarca F; Evangelista A; Liberati AM; Ledda A; Offidani M; Mina R; Larocca A;